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Abstract
Background: Longevity-associated mitochondrial DNA 5178 cytosine/adenine (Mt5178 C/A) polymorphism modulates
the effects of coffee consumption on the risk of hypertension, dyslipidemia, and abnormal glucose tolerance.
The objective of this study was to investigate whether Mt5178 C/A polymorphism modifies the effects of
coffee consumption on abnormally elevated levels of serum liver enzymes in male Japanese health check-up
examinees.
Methods: A total of 421 male subjects (mean age ± SD, 54.1 ± 7.7 years) were selected from among individuals visiting
the hospital for regular medical check-ups. After Mt5178 C/A genotyping, a cross-sectional study assessing the
joint effects of Mt5178 C/A polymorphism and coffee consumption on elevated levels of serum aspartate
aminotransferase (AST), serum alanine aminotransferase (ALT), and serum gamma-glutamyl transpeptidase
(GGT) was then conducted.
Results: For men with Mt5178C, after adjustment for age, body mass index, alcohol consumption, habitual
smoking, green tea consumption, antihypertensive treatment, and antidiabetic treatment, elevated levels of
serum AST, as defined as ≥30 U/L; those of serum ALT, as defined as ≥25 U/L; or those of serum GGT, as
defined as ≥60 or >51 U/L, may depend on coffee consumption (P for trend = 0.013, P for trend <0.001, P for
trend = 0.002, and P for trend <0.001, respectively). On the other hand, no significant joint effects of Mt5178A
genotype and coffee consumption on elevated levels of serum liver enzymes were observed.
Conclusions: The present results suggest that Mt5178 C/A polymorphism modifies the effects of coffee consumption
on abnormally elevated levels of serum liver enzymes in male Japanese health check-up examinees.
Keywords: Coffee consumption, Longevity, Mitochondrial DNA polymorphism, Personalized prevention, Serum liver
enzymes
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Background
Coffee is an increasingly popular beverage worldwide,
and coffee intake has been reported to have beneficial
effects on health [1, 2]. Recently, Saab et al. published a
systematic review of studies on the effects of coffee
consumption on liver cirrhosis, chronic hepatitis B and
hepatitis C, non-alcoholic fatty liver disease (NAFLD),
and hepatocellular carcinoma [3]. They recommend
daily coffee consumption to patients with chronic liver
disease. Their systematic review also summarized epi-
demiological surveys reporting the inverse association
between coffee consumption and elevated levels of
serum liver enzymes, namely serum aspartate amino-
transferase (AST) [4, 5], serum alanine aminotransferase
(ALT) [4–7], and serum gamma-glutamyl transpeptidase
(GGT) [4, 8].
Mitochondrial DNA 5178 cytosine/adenine (Mt5178
C/A) polymorphism (rs28357984), also known as NADH
dehydrogenase subunit-2 237 leucine/methionine (ND2-
237 Leu/Met) polymorphism, is associated with longev-
ity in the Japanese population [9]. The frequency of the
Mt5178A genotype is significantly higher in Japanese
centenarians than in the general population [9]. Japanese
individuals with Mt5178A are more resistant to lifestyle-
related adult onset diseases, such as hypertension [10],
diabetes [11], myocardial infarction [12, 13], and cere-
brovascular disorders [14], than those with Mt5178C.
Mt5178 C/A polymorphism influences the effects of
coffee consumption on the risk of hypertension [15],
those of abnormal glucose tolerance [16], those of
hyper-low-density lipoprotein (LDL) cholesterolemia
[17], and those of anemia [18]. Moreover, this poly-
morphism modulates the effects of cigarette smoking on
elevated levels of serum liver enzymes [19]. However,
there has been no research on the gene-environment in-
teractions between Mt5178 C/A polymorphism and coffee
consumption on elevated levels of serum liver enzymes.
The objective of this study is to investigate whether
there is a combined effect of longevity-associated
Mt5178 C/A polymorphism and coffee consumption on
abnormally elevated levels of serum liver enzymes in
male Japanese health check-up examinees.
Subjects and methods
Subjects
Participants were recruited from among individuals visit-
ing the Mito Red Cross Hospital for regular medical
check-ups between August 1999 and August 2000. This
study was conducted in accordance with the Declaration
of Helsinki and was approved by the Ethics Committee
of the Kyorin University School of Medicine. Written
informed consent was obtained from 602 volunteers
before participation. Because the number of women was
insufficient for classification into groups based on
Mt5178 C/A genotype and coffee consumption, female
health check-up examinees were excluded. Male health
check-up examinees with unclear clinical data were also
excluded. Thus, 442 men were enrolled in the study.
Twenty-one individuals with a history of chronic liver
diseases, including hepatitis B and hepatitis C, were also
excluded. Therefore, subjects comprised 421 Japanese
men (age, 54.1 ± 7.7 years; mean ± SD).
Clinical characteristics of subjects
Blood chemical and physical data, including serum AST,
ALT, and GGT levels, in the present study were obtained
from the results of regular medical check-ups [20]. Ele-
vated levels of serum AST were defined as ≥30 U/L [21].
Elevated levels of serum ALT were defined as >30 U/L
[22] or ≥25 U/L [23]. Elevated levels of serum GGT were
defined as ≥60 U/L [24, 25] or >51 U/L [26, 27]. Body
mass index (BMI) was defined as the ratio of subject
weight (kg) to the square of subject height (m). Infor-
mation on antihypertensive treatment or antidiabetic
treatment was derived from health check-up records.
A survey of coffee intake, alcohol consumption, and
habitual smoking was performed by means of a ques-
tionnaire. Taking into account sample size in this
study and others [7], coffee consumption was catego-
rized based on the number of cups of coffee per day
(<1 cup per day; 1–2 cups per day; and ≥3 cups per
day). Green tea consumption was also categorized
based on the number of cups of green tea per day
(≤1 cup per day; 2–3 cups per day; and ≥4 cups per day).
Alcohol consumption was classified based on drinking fre-
quency (daily drinkers; occasional drinkers, including
those who drink several times per week or per month; and
non- or ex-drinkers). Smoking status was classified based
on the number of cigarettes smoked per day (never- or
ex-smokers; 1–20 cigarettes smoked per day; and >20
cigarettes smoked per day).
Genotyping
DNA was extracted from white blood cells using the
DNA Extractor WB kit (Wako Pure Chemical Industries,
Osaka, Japan). Mt5178 C/A polymorphism was detected
by PCR and digestion with AluI restriction enzyme as
described previously [10, 15–20]. Primers were forward
5′-CTTAGCATACTCCTCAATTACCC-3′ and reverse
5′-GTGAATTCTTCGATAATGGCCCA-3′. PCR was
performed with 50 ng of genomic DNA in buffer con-
taining 0.2 μmol/L of each primer, 1.25 mmol/L dNTPs,
1.5 mmol/L MgCl2, and 1 U of Taq DNA polymerase
(GeneAmp, PerkinElmer, Branchburg, NJ, USA). After
an initial denaturation at 94 °C for 5 min, PCR was con-
ducted through 40 cycles in the following steps: denatur-
ation at 94 °C for 30 s, annealing at 60 °C for 60 s, and
polymerase extension at 72 °C for 90 s. After cycling, a
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final extension at 72 °C for 10 min was performed. PCR
products were digested with AluI restriction enzyme
(Nippon Gene, Tokyo, Japan) at 37 °C overnight and
were electrophoresed in 1.5 % agarose gels stained with
ethidium bromide for visualization under ultraviolet
light. The absence of an AluI site was designated as
Mt5178A, and the presence of this restriction site was
designated as Mt5178C.
Statistical analyses
Statistical analyses were performed using SAS statistical
software version 9.4 for Windows. Multiple logistic
regression analysis was used to calculate odds ratios
(ORs) for abnormally elevated levels of serum liver
enzymes (AST ≥30 U/L; ALT >30 or ≥25 U/L; GGT ≥60
or >51 U/L). For multiple logistic regression analysis, al-
cohol consumption (non- or ex-drinkers = 0; occasional
drinkers, including those who drink several times per
week or per month = 1; daily drinkers = 2), habitual
smoking (non- or ex-smokers = 0; 1–20 cigarettes
smoked per day = 1; >20 cigarettes smoked per day = 2),
green tea consumption (≤1 cup per day = 1; 2–3 cups
per day = 2; ≥4 cups per day = 2), antihypertensive treat-
ment (subjects without antihypertensive treatment = 0;
those under antihypertensive treatment = 1), and anti-
diabetic treatment (subjects without antidiabetic treat-
ment = 0; those under antidiabetic treatment = 1) were
numerically coded. Differences with P values of less than
0.05 were considered to be statistically significant.
Results
Except for the AST/ALT ratio, no significant differences in
clinical characteristics were observed between the
Mt5178C and Mt5178A genotypes (Table 1). The AST/
Table 1 Clinical characteristics of study subjects by Mt5178 C/A genotype
Mt5178C Mt5178A P value
N = 251 N = 170
Age (years)a 54.5 (7.6) 53.6 (7.8) 0.245
BMI (kg/m2)a 23.1 (2.8) 23.5 (2.6) 0.103
SBP (mmHg)b 126.1 (16.0) 125.3 (13.9) 0.614
DBP (mmHg)b 73.9 (10.5) 73.5 (9.0) 0.628
AST (U/L)c 22 (18–27) 23 (19–27) 0.687
ALT (U/L)c 21 (15–32) 24 (18–35) 0.471
AST/ALT ratioc 1.037 (0.818–1.286) 0.918 (0.723–1.190) 0.004
GGT (U/L)c 42 (27–75) 47 (30–75) 0.427
TC (mg/dL)a 204.2 (31.5) 202.5 (31.9) 0.590
LDL-C (mg/dL)a 122.5 (30.4) 118.4 (31.7) 0.182
HDL-C (mg/dL)b 55.1 (13.6) 55.9 (15.7) 0.576
TG (mg/dL)c 112 (84–156) 113 (83–161) 0.378
Subjects with ≥140 mg/dL LDL-C (%)d 25.5 27.1 0.721
Subjects with ≥150 mg/dL TG (%)d 28.3 29.4 0.803
FPG (mg/dL)c 97 (92–105) 97 (91–103) 0.240
UA (mg/dL)a 5.93 (1.28) 5.98 (1.21) 0.686
Coffee consumption (<1 cup per day/1–2 cups per day/≥3 cups per day) (%)d 45.8/31.5/22.7 36.5/40.0/23.5 0.120
Green tea consumption (≤1 cup per day/2–3 cups per day/≥4 cups per day) (%)d 26.7/30.7/42.6 27.7/32.9/39.4 0.798
Alcohol consumption (non- or ex-/occasionally/daily drinkers) (%)d 17.9/34.3/47.8 12.9/40.0/47.1 0.285
Current smokers (%)d 58.6 58.2 0.946
Subjects under antihypertensive treatment (%)d 19.9 13.5 0.089
Subjects under antidiabetic treatment (%)d 7.2 7.7 0.855
Age, BMI, SBP, DBP, TC levels, LDL-C levels, HDL-C levels, and UA levels are given as means (S.D.). AST levels, ALT levels, AST/ALT ratio, GGT levels, TG levels, and
FPG levels are given as medians (interquartile range). All P values depict significance of differences between Mt5178C and Mt5178A
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma-glutamyl
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ALT ratio was significantly higher in subjects with
Mt5178C than in those with Mt5178A (P = 0.004). Al-
though the difference did not reach significance (P = 0.089),
the frequency of subjects under antihypertensive treatment
was higher in Mt5178C genotypic men than in Mt5178A
genotypic men.
For subjects with Mt5178C, elevated levels of serum
AST may depend on coffee consumption (P for trend =
0.026) (Table 2). The OR for elevated levels of serum
AST was significantly lower in subjects with Mt5178C
who consumed ≥3 cups of coffee per day than in those
who consumed <1 cup per day (OR = 0.366, 95 % confi-
dence interval (CI) 0.142–0.942, P = 0.037). After adjust-
ment for age, BMI, alcohol consumption, habitual
smoking, antihypertensive treatment, and antidiabetic
treatment, elevated levels of serum AST may also de-
pend on coffee consumption (P for trend = 0.013). The
OR for elevated levels of serum AST was significantly
lower in subjects with Mt5178C who consumed ≥3 cups
of coffee per day than in those who consumed <1 cup
per day (OR = 0.242, 95 % CI 0.081–0.730, P = 0.012).
On the other hand, the association between Mt5178A
genotype and elevated levels of serum AST does not ap-
pear to depend on coffee consumption.
In the case of elevated serum ALT levels, as defined
as >30 U/L, for either Mt5178 C/A genotypes, no sig-
nificant relationship between coffee consumption and
elevated levels of serum ALT was observed (Table 3).
However, in the case of elevated serum ALT levels, as de-
fined as ≥25 U/L, for subjects with Mt5178C, elevated
levels of serum ALT may depend on coffee consumption
(P for trend = 0.015). The OR for elevated levels of serum
ALT was significantly lower in subjects with Mt5178C
who consumed ≥3 cups of coffee per day than in those
who consumed <1 cup per day (OR = 0.409, 95 % CI
0.202–0.828, P = 0.013). After adjustment for age, BMI, al-
cohol consumption, habitual smoking, antihypertensive
treatment, and antidiabetic treatment, elevated levels of
serum ALT may also depend on coffee consumption (P
for trend <0.001). The OR for elevated levels of serum
ALT was significantly lower in subjects with Mt5178C
who consumed ≥3 cups of coffee per day than in those
who consumed <1 cup per day (OR = 0.198, 95 % CI
0.077–1.129, P < 0.001). On the other hand, the associ-
ation between Mt5178A genotype and elevated levels of
serum ALT does not appear to depend on coffee
consumption.
In the case of elevated levels of serum GGT, as defined
as ≥60 or >51 U/L, for subjects with Mt5178C, elevated
levels of serum GGT may depend on coffee consump-
tion (P for trend = 0.049 and P for trend = 0.015, respect-
ively) (Table 4). The OR for elevated levels of serum
GGT, as defined as ≥60 or >51 U/L, was significantly
lower in subjects with Mt5178C who consumed ≥3 cups
of coffee per day than in those who consumed <1 cup
per day (OR = 0.488, 95 % CI 0.240–0.993, P = 0.048 and
OR = 0.418, 95 % CI 0.209–0.837, P = 0.014, respect-
ively). After adjusting for age, BMI, alcohol consump-
tion, habitual smoking, antihypertensive treatment,
and antidiabetic treatment, elevated levels of serum
GGT, as defined as ≥60 or >51 U/L, may also depend
on coffee consumption (P for trend = 0.002 and P for
trend <0.001, respectively). After the aforementioned
adjustment, the OR for elevated levels of serum GGT, as
defined as ≥60 or >51 U/L, was significantly lower in sub-
jects with Mt5178C who consumed ≥3 cups of coffee per
day than in those who consumed <1 cup per day (OR =
0.313, 95 % CI 0.110–0.640, P = 0.003 and OR = 0.231,
Table 2 Odds ratios (ORs) and 95 % confidence intervals (CIs) for high levels of serum aspartate aminotransferase (AST) by Mt5178
C/A genotype and coffee consumption
Genotype and coffee consumption Frequency (%) OR (95 % CI) Adjusted ORa (95 % CI)
Normal levels of serum AST High levels of serum AST
Serum AST levels <30 U/L Serum AST levels ≥30 U/L
Mt5178C
<1 cup per day 87 (75.6) 28 (25.4) 1 (reference) 1 (reference)
1–2 cups per day 66 (83.5) 13 (16.5) 0.612 (0.295–1.272) 0.490 (0.212–1.134)
≥3 cups per day 51 (89.5) 6 (10.5) 0.366 (0.142–0.942)* 0.242 (0.081–0.730)*
P for trend = 0.026 P for trend = 0.013
Mt5178A
<1 cup per day 49 (79.0) 13 (21.0) 1 (reference) 1 (reference)
1–2 cups per day 56 (82.4) 12 (17.6) 0.808 (0.337–1.934) 0.833 (0.294–2.362)
≥3 cups per day 34 (85.0) 6 (15.0) 0.665 (0.230–1.923) 0.818 (0.231–2.901)
P for trend = 0.438 P for trend = 0.656
*P < 0.05
aOR adjusted for age, body mass index, habitual alcohol consumption, habitual smoking, green tea consumption, antihypertensive treatment, and antidiabetic treatment
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95 % CI 0.095–0.561, P = 0.001, respectively). On the other
hand, the association between Mt5178A genotype and ele-
vated levels of serum GGT does not appear to depend on
coffee consumption.
Discussion
In the present study, the joint defensive effect of Mt5178
C/A polymorphism and coffee consumption on the
elevation of serum liver enzymes, namely AST, ALT, and
GGT, was observed in male Japanese health check-up
examinees. Considering that coffee consumption pro-
tects hepatocytes from viruses, alcohol, drugs, or other
aggressors [1], habitual coffee drinking is expected to
exert a desirable effect on the liver in either genotype.
For subjects with Mt5178C genotype, more consump-
tion of coffee may reduce the risk of elevated levels of
AST, ALT, and GGT. On the other hand, for those with
Mt5178A, coffee consumption does not appear to influ-
ence abnormally elevated levels of serum liver enzymes.
Several large-scale cross-sectional studies have shown
an inverse association between coffee consumption and
abnormally elevated levels of serum liver enzymes in
populations in Europe [8], the USA [4, 7], and Japan
[5, 6]. In the aforementioned epidemiological studies
[4–8], age, BMI, alcohol consumption, and habitual
smoking were considered to be confounders or effect
modifiers. However, genetic factors were not included
as confounding factors or effect modifiers in either
study. Considering our results, the addition of gen-
etic information may contribute to future epidemio-
logical studies with regard to the effects of coffee
consumption on elevated levels of serum liver
enzymes.
The genetic frequency of Mt5178C is markedly higher
in European, American, and African populations than in
Asian populations [28]. This is probably the cause of the
inverse association between coffee consumption and ele-
vated levels of serum liver enzyme observed in Europe
[8] and the USA [4, 7]. However, we cannot rule out the
possibility that coffee consumption alone modulates
serum liver enzyme levels, irrespective of Mt5178 C/A
polymorphism.
Table 3 Odds ratios (ORs) and 95 % confidence intervals (CIs) for high levels of serum alanine aminotransferase (ALT) by Mt5178 C/
A genotype and coffee consumption
Genotype and
coffee consumption
Frequency (%) OR (95 % CI) Adjusted ORa (95 % CI)
Normal levels of serum ALT High levels of serum ALT
Serum ALT levels ≤30 U/L Serum ALT levels >30 U/L
Mt5178C
<1 cup per day 82 (71.3) 33 (28.7) 1 (reference) 1 (reference)
1–2 cups per day 56 (70.9) 23 (29.1) 1.021 (0.543–1.919) 0.797 (0.375–1.694)
≥3 cups per day 45 (79.0) 12 (21.0) 0.663 (0.312–1.409) 0.407 (0.148–1.115)
P for trend = 0.346 P for trend = 0.090
Mt5178A
<1 cup per day 41 (66.1) 21 (33.9) 1 (reference) 1 (reference)
1–2 cups per day 51 (75.0) 17 (25.0) 0.651 (0.304–1.392) 0.416 (0.160–1.080)
≥3 cups per day 26 (65.0) 14 (35.0) 1.051 (0.456–2.425) 0.695 (0.249–1.941)
P for trend = 0.953 P for trend = 0.285
Serum ALT levels <25 U/L Serum ALT levels ≥25 U/L
Mt5178C
<1 cup per day 64 (55.6) 51 (44.4) 1 (reference) 1 (reference)
1–2 cups per day 49 (62.0) 30 (38.0) 0.768 (0.428–1.379) 0.556 (0.274–1.129)
≥3 cups per day 43 (75.4) 14 (24.6) 0.409 (0.202–0.828)* 0.198 (0.077–0.512)**
P for trend = 0.015 P for trend < 0.001
Mt5178A
<1 cup per day 32 (51.6) 30 (48.4) 1 (reference) 1 (reference)
1–2 cups per day 38 (55.9) 30 (44.1) 0.842 (0.422–1.680) 0.805 (0.364–1.781)
≥3 cups per day 22 (55.0) 18 (45.0) 0.873 (0.393–1.938) 0.585 (0.212–1.611)
P for trend = 0.701 P for trend = 0.353
*P < 0.05; **P < 0.001
aOR adjusted for age, body mass index, habitual alcohol consumption, habitual smoking, green tea consumption, antihypertensive treatment, and antidiabetic treatment
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Serum ALT levels are a marker of liver cell injury [29],
as well as NAFLD, hepatocellular carcinoma, type 2
diabetes, and cardiovascular disease [30]. In the present
study, two different definitions of elevated serum ALT
levels, >30 U/L [22] or ≥25 U/L [23], were used. Based
on a large-scale community-based study including sub-
jects who consumed <20 g of alcohol per day, Miyake
et al. estimated the ATL cutoff levels for NAFLD at
25 U/L for Japanese men [23]. Among Mt5178C geno-
typic men who are reportedly susceptible to cardiovascu-
lar diseases [12–14], the OR for ≥25 U/L of serum ALT,
surrogate marker for NAFLD, was significantly lower in
subjects who consumed ≥3 cups of coffee per day than
in those who consumed <1 cup per day. Moreover, a
large-scale population-based prospective study found
that elevated levels of serum GGT (>51 U/L in men
and >33 U/L in women) are associated with not only
liver disease mortality but also mortality from all causes,
malignancy, and diabetes [26]. A cross-sectional study
showed the association between serum GGT activity and
metabolic risk factors for cardiovascular disease among
Japanese men [31]. Among Mt5178C genotypic men, the
OR for elevated levels of serum GGT was significantly
lower in subjects who consumed ≥3 cups of coffee per day
than in those who consumed <1 cup per day. Therefore,
coffee consumption may have a preventative effect on
liver damage, as well as cardiovascular disease, in men
with Mt5178C.
Personalized prevention by behavior modification of
coffee intake may be more suitable for men with
Mt5178C than for those with Mt5178A. Among
Mt5178C genotypic men, the risk of hypertension was
significantly lower in subjects who consumed ≥2 cups of
coffee per day than in those who consumed ≤1 cup of
coffee per day [15], and that of abnormal glucose
tolerance was also significantly lower in subjects who
consumed ≥4 cups of coffee per day than in those who
consumed <1 cup of coffee per day [16]. On the other
hand, among Mt5178A genotypic men, the risk of
hyper-LDL cholesterolemia was significantly higher in
subjects who consumed ≥1 cup of coffee per day than in
those who consumed <1 cup of coffee per day [17].
Table 4 Odds ratios (ORs) and 95 % confidence intervals (CIs) for high levels of serum gamma-glutamyltransferase (GGT) by Mt5178
C/A genotype and coffee consumption
Genotype and
coffee consumption
Frequency (%) OR (95 % CI) Adjusted ORa (95 % CI)
Normal levels of serum GGT High levels of serum GGT
Serum GGT levels <60 U/L Serum GGT levels ≥60 U/L
Mt5178C
<1 cup per day 69 (60.0) 46 (40.0) 1 (reference) 1 (reference)
1–2 cups per day 52 (65.8) 27 (34.2) 0.779 (0.429–1.414) 0.575 (0.280–1.177)
≥3 cups per day 43 (75.4) 14 (24.6) 0.488 (0.240–0.993)* 0.313 (0.110–0.640)**
P for trend = 0.049 P for trend = 0.002
Mt5178A
<1 cup per day 41 (66.1) 21 (33.9) 1 (reference) 1 (reference)
1–2 cups per day 36 (52.9) 32 (47.1) 1.735 (0.854–3.528) 1.775 (0.775–4.066)
≥3 cups per day 27 (67.5) 13 (32.5) 0.940 (0.404–2.189) 0.838 (0.320–2.190)
P for trend = 0.911 P for trend = 0.711
Serum GGT levels ≤51 U/L Serum GGT levels >51 U/L
Mt5178C
<1 cup per day 62 (53.9) 53 (46.1) 1 (reference) 1 (reference)
1–2 cups per day 48 (60.8) 31 (39.2) 0.756 (0.422–1.352) 0.569 (0.280–1.155)
≥3 cups per day 42 (73.7) 15 (26.3) 0.418 (0.209–0.837)* 0.231 (0.095–0.561)**
P for trend = 0.015 P for trend < 0.001
Mt5178A
<1 cup per day 37 (59.7) 25 (40.3) 1 (reference) 1 (reference)
1–2 cups per day 32 (47.1) 36 (52.9) 1.665 (0.830–3.339) 1.709 (0.746–3.911)
≥3 cups per day 23 (57.5) 17 (42.5) 1.094 (0.488–2.450) 1.025 (0.412–2.549)
P for trend = 0.673 P for trend = 0.988
*P < 0.05, **P < 0.005
aOR adjusted for age, body mass index, habitual alcohol consumption, habitual smoking, green tea consumption, antihypertensive treatment, and antidiabetic treatment
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Taken together, the present results suggest that coffee
intake is more effective at reducing the risk of cardiovas-
cular disease in men with Mt5178C than in those with
Mt5178A. However, from the viewpoint of prevention of
anemia, coffee consumption may not be recommended
for Mt5178C genotypic men [18].
The mechanisms of the joint protective effects of
Mt5178 C/A polymorphism and coffee consumption on
elevated levels of serum liver enzymes remain unknown.
They presumably depend on the biophysical and bio-
chemical differences in the response to certain com-
pounds in coffee between ND2-237Leu and ND2-
237Met. NADH dehydrogenase, complex I of respiratory
chain, is regarded as the major physiological and patho-
logical site of reactive oxygen species (ROS) generation
in mitochondria and itself as a target of assault by ROS
[32]. Mouse mitochondrial DNA 4738 C/A (Mt4738 C/A)
polymorphism also leads to a leucine to methionine
substitution in NADH dehydrogenase subunit 2. ROS
production by NADH dehydrogenase is significantly lower
in mice with Mt4738A than in those with Mt4738C [33].
Extrapolation from experimental animal models to
humans suggests that ND2-237Met suppresses ROS
production. Moreover, as methionine residues act as
endogenous antioxidants [34], ND2-237Met may also
protect NADH dehydrogenase itself from ROS attack.
Thus, Mt5178A genotype is thought to be clinically
[10–14] and pathologically [33, 34] superior to Mt5178C
genotype. Coffee intake exerts antioxidant potential in
human subjects [35, 36]. However, the reasons why coffee
consumption exerts antioxidant effects on liver in ND2-
237Leu genotypic men rather than in longevity-associated
ND2-237Met genotypic men remain uncertain. In any
case, elucidation of the mechanisms of the combined
defensive effects of Mt5178 C/A (ND2-237 Leu/Met)
polymorphism and coffee consumption on abnormally
elevated levels of serum liver enzymes remains a matter
for further biochemical investigation.
Mera et al. reported that the distribution of the AST/
ALT ratio by age decade is U-shaped: high in the 1st and
2nd decades, declining to a nadir in the 4th decade, then
rising in the 10th and 11th decades [37]. NADH de-
hydrogenase, centrally regulating the aging process [38],
may be relevant to our finding that the AST/ALT ratio
was significantly higher in Mt5178C genotypic men than
in Mt5178A genotypic men. However, the AST/ALT
ratio, clinically useful to assist in differential diagnosis of
hepatic disease [39], was not associated with coffee
consumption in either Mt5178C or Mt5178A genotypic
men (data not shown).
Hepatic status and lipid status may mutually affect one
another. NAFLD is clinically associated with detrimental
changes in lipid and lipoprotein profiles [40]. On the other
hand, statins, lipid-lowering agents, exert substantial
improvement in serum liver enzyme levels in patients with
NAFLD [41]. Due to unclear data on antidyslipidemic
drugs, further research will be required to investigate
gene-environment interactions on serum liver enzyme
levels after adjustment for statin use. As mentioned above,
Mt5178 C/A polymorphism modifies the effects of coffee
consumption on serum LDL cholesterol levels [17]. Coffee
consumption raises serum LDL cholesterol levels in only
Mt5178A genotypic men. This effect may obscure the
interaction of Mt5178 C/A polymorphism and coffee
consumption on serum liver enzyme levels in men with
Mt5178A.
In addition to a lack of information on antidyslipi-
demic drugs, there are several crucial limitations in this
study. First, the study sample was very small. Therefore,
it is possible that false-negative results were obtained in
statistical analyses for subjects with Mt5178A. We
should consider the possibility that elevated levels of
serum liver enzymes are modulated by the effects of cof-
fee consumption alone and not by the joint effects of
Mt5178 C/A polymorphism and coffee consumption.
Second, we analyzed only a single population. Third, this
was an exploratory cross-sectional study. To overcome
these limitations, a prospective study with a larger sam-
ple including a range of ethnic populations is necessary.
Fourth, the evaluation of habitual coffee consumption
was based on the number of cups consumed per day.
Whether there is any interaction between Mt5178 C/A
polymorphism and volume of chlorogenic acids, caffeine,
or other compounds in coffee on elevated levels of
serum liver enzymes warrants further investigation.
Moreover, considering that the type of coffee prepar-
ation influences serum liver enzymes [8, 42], information
regarding the method of coffee preparation will be
required. Fifth, because of a lack of data on the amount
of alcohol intake, the evaluation of habitual alcohol in-
take was based on the frequency of alcohol consump-
tion. Alcohol consumption was treated as one of the
confounding factors in statistical analysis in this study.
The existence of combined effects between Mt5178 C/A
polymorphism and volume of alcohol intake on elevated
levels of serum liver enzymes warrants further
investigation.
Conclusion
This exploratory cross-sectional study suggests that
Mt5178 C/A polymorphism modulates the effects of
coffee consumption on elevated levels of serum liver
enzymes in male Japanese health check-up examinees.
To the best of our knowledge, this is a novel gene-
environment interaction on abnormally elevated levels of
serum AST, ALT, and GGT levels. Although abstaining
from coffee intake is advocated for men with Mt5178C in
order to reduce the risk of anemia [18], coffee
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consumption may be recommended for them in order to
reduce the risk of liver injury, NAFLD, hypertension [15],
and abnormal glucose tolerance [16]. This genetic infor-
mation may contribute to individualized prevention of
liver injury, NAFLD, and cardiovascular diseases. More-
over, the identification of gene-environment interactions
across diverse populations with various lifestyles may
contribute to cultural and physiological anthropology [43].
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